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Introduction Methods 
Conclusions 
We hypothesized that the femoral I/R vein will exhibit increased levels of 
H2O2 in the blood when compared to the sham vein in the same 
anesthetized rat. Moreover, we predict that there will be a concurrent 
decrease in levels of NO released in the femoral I/R vein compared to the 
sham vein. When mitoQ or SS-31 is given at reperfusion, we expect that 
the I/R limbs will show decreased H2O2 blood levels and increased NO 
blood levels compared to the non-drug treated saline controls. As a result, 
there will be a decrease in ROS and I/R injury. 
When mitoQ or SS-31 is given at the beginning of reperfusion, there is a 
significant reduction of blood H2O2 and a significant increase in 
endothelial-derived NO bioavailablity compared to saline controls. The 
results of this study support our hypothesis that mitochondria-targeted 
antioxidant agents can significantly attenuate reperfusion induced ROS 
release and lead to an increase in NO bioavailability. Collectively, the data 
suggests that mitoQ or SS-31 can be effective tools in the clinical setting 
for attenuating post-ischemic insult and endothelial dysfunction. The 
results also suggest that mitochondrial derived ROS significantly 
contributes to increased blood H2O2 levels and decreased NO blood 
levels during reperfusion. Moreover, the mitochondria-targeted antioxidant 
agents mitoQ or SS-31 were able to attenuate the changes in blood H2O2 
and NO levels suggesting that mitochondrial derived ROS are major 
contributors to oxidative stress in I/R injury. 
Male Sprague-Dawley (SD) rats (275-325 grams, Charles River, 
Springfield, MA) were anesthetized with an induction dose of 60mg/kg and 
maintenance dose 30mg/kg of sodium pentobarbital intraperitoneally (i.p.). 
The rats also received sodium heparin (1000 USP units/mL) i.p. to act as 
an anticoagulant. We measured blood H2O2 or NO release from femoral 
veins in real-time: one vein was subjected to I/R while the other was used 
as a non-ischemic sham control. The H2O2 or NO microsensors (100 μm, 
WPI Inc., Sarasota, FL) were connected to a free radical analyzer (Apollo 
4000, WPI Inc.) and were inserted into a catheter placed in each femoral 
vein. Ischemia was induced by clamping the femoral artery/vein of one 
limb for 30 min followed by 45 min of reperfusion. MitoQ (2 mg/kg),  SS-31 
(2.5 mg/kg), or saline (for non-drug control group) was administered as a 
bolus injection via the jugular vein at the beginning of reperfusion. We 
continuously recorded the H2O2 or NO release and collected the data at 5 
min intervals  during a 15 min baseline period, 30 min ischemia and 45 
min reperfusion. The changes in H2O2 or NO release during reperfusion (in 
picoamps) are expressed as relative change to baseline after correction to 
the calibration curve of H2O2 (μM) or NO (nM) microsensors. Experimental 
groups were compared with Student‘s t-test or ANOVA using post hoc 
analysis with the Student-Newman-Keuls test. 
 
Figure 6. Comparison of relative difference in H2O2 release between I/R and sham 
femoral veins during reperfusion in saline, mitoQ, or SS-31 groups. There was a 
significant decrease in H2O2 release in the mitoQ-treated and SS-31 treated groups 
from 10-35 min of reperfusion and 15-45 min respectively (MitoQ * p<0.05, SS-31 # 
p<0.05, ## p<0.01 from saline controls using ANOVA).   
Figure 3. The experimental preparation for measuring blood H2O2 or NO release from   
I/R and sham femoral veins in the male SD rats. 
 
Hypothesis 
Figure 5. Comparison of relative difference in NO release between I/R and sham 
femoral veins during reperfusion.  There was a significant increase in NO release in the 
mitoQ-treated group at 25 min and 30 min of reperfusion (* p<0.05 from saline control 
using Student’s t-test).  
In the body, reperfusion of ischemic tissue with blood causes the release 
of reactive oxygen species (ROS), in part, from damaged mitochondria 
leading to endothelial and organ dysfunction. Endothelial dysfunction 
occurs within 5 min of reperfusion, is common to all vascular beds, and is 
characterized by increased hydrogen peroxide (H2O2) and decreased nitric 
oxide (NO) levels in the blood that further exacerbate reperfusion injury. 
Previous studies have shown that promoting endothelial NO synthase 
coupling during reperfusion increases blood NO and decreases blood 
H2O2 levels in hind limb I/R and attenuates myocardial I/R injury (1). This 
study specifically examines the effects mitochondria-targeted antioxidants, 
mitoquinone (mitoQ; Fig. 1), a cell permeable coenzyme Q analogue or 
SS-31 ((D-Arg)-Dmt-Lys-Phe-Amide; Genemed Synthesis, San Antonio, 
TX) (Fig.1), a cell permeable peptide, on inhibiting H2O2 release and 
increasing NO bioavailability in hind limb I/R. MitoQ (2) and SS-31 (3,4) 
are able to concentrate into the inner mitochondrial membrane via an 
electrical potential gradient or selective diffusion respectively, where they 
attenuate superoxide and subsequent H2O2 production thus allowing a 
concurrent increase in NO bioavailability (Fig.2).     
 
Figure 2. Schematic showing the mitochondrial mode of action of both mitoQ 
and SS-31 peptide. Red-lines denote areas of inhibition. Adapted from Szeto 
2006. 
Figure 1. Mitoquinone (mitoQ; 600g/mol) and SS-31 (642g/mol) molecular 
structure.  
Results 
Figure 4. The time course of change in H2O2 (μM) or NO (nM) release from anesthetized 
rat femoral veins in the saline control group. (a) There was a significant increase in H2O2 
release during the first 25 min of reperfusion from I/R veins compared to sham veins in 
saline controls (* p<0.05, **p<0.01 from sham).  
(b)  There was a significant decrease in NO release from I/R veins compared to sham 
veins from 20-45 min reperfusion in saline controls. I/R and sham limbs were compared 
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